Fabian Müller

Fabian Müller is a researcher at University Hospital Erlangen in Germany. He is part of a team that has achieved a significant breakthrough in treating severe autoimmune diseases using CAR-T cell therapy. This therapy, typically used for blood cancers, was applied to a 47-year-old woman suffering from three life-threatening autoimmune conditions that had been unresponsive to nine previous treatments. The patient required daily blood transfusions before the therapy. The CAR-T treatment involved genetically modifying the patient's own immune cells to target and eliminate the malfunctioning immune cells responsible for the autoimmune attacks. Following the therapy, the patient experienced a 'remarkable' recovery, returning to a near-normal life. This case, published in the journal *Med*, highlights the potential of CAR-T therapy to treat a wider range of diseases beyond cancer, specifically offering hope for individuals with severe and treatment-resistant autoimmune disorders. Müller's work is significant because it expands the application of a powerful cancer treatment to a new area of medicine.